Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB

Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites

(2015) Zaid H. Maayah et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

208 The PKC Epsilon/AMPK ALPHA/ENOS Pathway is Implicated as a Mechanism by which Remote Ischaemic Conditioning Attenuates Endothelin-1 Mediated Cardiomyocyte Hypertrophy

(2014) Andrew Vanezis et al.   HEART

EPC-Derived Microvesicles Protect Cardiomyocytes from Ang II-Induced Hypertrophy and Apoptosis

(2014) Shenhong Gu et al.   PLoS One

Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation

(2013) Zaid H. Maayah et al.   ARCHIVES OF TOXICOLOGY

Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy

(2013) Ahmed A. El-Sherbeni et al.   BIOCHEMICAL PHARMACOLOGY

20-Hydroxyeicosatetraenoic Acid is a Potential Therapeutic Target in Cardiovascular Diseases

(2013) Osama Elshenawy et al.   CURRENT DRUG METABOLISM

Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line

(2013) Mandy M.Y. Tse et al.   VASCULAR PHARMACOLOGY

Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy

(2012) Hassan N Althurwi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling

(2012) Jing Zong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Murine atrial HL-1 cell line is a reliable model to study drug metabolizing enzymes in the heart

(2012) Osama H. Elshenawy et al.   VASCULAR PHARMACOLOGY

Cytochrome P450 1B1 Contributes to Renal Dysfunction and Damage Caused by Angiotensin II in Mice

(2011) Brett L. Jennings et al.   HYPERTENSION

The role of 20-HETE in androgen-mediated hypertension

(2011) Cheng-Chia Wu et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: A novel target for antihypertensive agents

(2011) Kafait U. Malik et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?

(2011) Cristiano Fava et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases

(2010) Beshay N.M. Zordoky et al.   PHARMACOLOGY & THERAPEUTICS

Cardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure

(2009) Yosuke Kayama et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy

(2009) D. Ai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats

(2009) Beshay N.M. Zordoky et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Eicosanoid signalling pathways in the heart

(2008) C. M. Jenkins et al.   CARDIOVASCULAR RESEARCH

Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats

(2008) B. N. M. Zordoky et al.   DRUG METABOLISM AND DISPOSITION

Molecular regulation of cardiac hypertrophy

(2008) Sean P. Barry et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY